Latest News and Press Releases
Want to stay updated on the latest news?
-
Paris, 02 janv. 2025 (GLOBE NEWSWIRE) -- COMMUNIQUÉ RELATIF AU DÉPÔT D'UN PROJET D'OFFRE PUBLIQUE D'ACHAT SIMPLIFIÉE visant les actions Neoen (« Actions ») et les obligations convertibles...
-
Paris, Jan. 02, 2025 (GLOBE NEWSWIRE) -- THIS DOCUMENT IS AN UNOFFICIAL ENGLISH-LANGUAGE TRANSLATION OF THE FRENCH LANGUAGE PRESS RELEASE WHICH WAS PUBLISHED BY THE OFFEROR ON 2 JANUARY 2025. IN THE...
-
Bilbao, April 11 - Spanish listed company Virtualware (EPA:MLVIR), European leader in the industrial virtual reality sector, invites its shareholders to a meeting to review the Annual Results and...
-
BILBAO, Spain and PARIS, April 03, 2023 (GLOBE NEWSWIRE) -- European company Virtualware, one of the European leaders in the Virtual Reality industry, will start trading on Euronext Paris on April...
-
INFORMATION PRESSE Nanterre, le 4 août 2020 (après Bourse)Rubrique : C.A. 1er semestre 2020 Stabilité (+ 0,2%) du chiffre d’affaires au 1er semestre...
-
PRESS INFORMATION Nanterre, August 4, 2020 (after the closing of the stock exchange)Heading: 1st half 2020 revenues Revenues stable (+0.2%) in 1st half of 2020 Revenues (in millions...
-
Marseille, France, October 17, 2019, 8:30 AM CEST INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“Innate” or the “Company”), a French biotechnology company focused on discovering,...
-
Marseille, le 17 octobre 2019, 8h30 INNATE PHARMA S.A. (la « Société » - Euronext Paris : FR0010331421 – IPH), société de biotechnologie française spécialisée dans la découverte, le développement et...
-
Marseille, France, October 17, 2019, 8:30 AM CEST INNATE PHARMA S.A. (Euronext Paris: IPH – ISIN: FR0010331421) (“Innate” or the “Company”), a French biotechnology company focused on discovering,...
-
AMSTERDAM, The Netherlands, Jan. 31, 2018 (GLOBE NEWSWIRE) -- Constellium N.V. (NYSE:CSTM) (Euronext Paris:CSTM) (« Constellium ») today announced that the request by Constellium to delist its...